Cristiano, A.; Palmieri, R.; Fabiani, E.; Ottone, T.; Divona, M.; Savi, A.; Buccisano, F.; Maurillo, L.; Tarella, C.; Arcese, W. The Venetoclax Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient With COVID : VEN AZA Effectively Targets AML Clones. Mediterr J Hematol Infect Dis 2022, 14, e2022041.